Works matching IS 01615505 AND DT 2024 AND VI 65 AND IP 9

Results: 34

Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1387, doi. 10.2967/jnumed.124.267922

By:

Nikitas, John;
Castellanos Rieger, Angela;
Farolfi, Andrea;
Seyedroudbari, Ameen;
Kishan, Amar U.;
Nickols, Nicholas G.;
Steinberg, Michael L.;
Valle, Luca F.;
Rettig, Matthew;
Czernin, Johannes;
Calais, Jeremie

Publication type:

Article

Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of 225Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1456, doi. 10.2967/jnumed.123.266894

By:

Wichmann, Christian W.;
Morgan, Katherine A.;
Cao, Zhipeng;
Osellame, Laura D.;
Guo, Nancy;
Gan, Hui;
Reilly, Edward;
Burvenich, Ingrid J.G.;
O'Keefe, Graeme J.;
Donnelly, Paul S.;
Scott, Andrew M.

Publication type:

Article

FINDing the Future of Radiopharma.

Published in:

2024

By:

Behrenbruch, Christian

Publication type:

Editorial

Reply: The Potential Value of Functional Adrenal Imaging in Primary Aldosterone.

Published in:

2024

By:

Li, Xiang;
Huo, Li

Publication type:

Letter

Robert Carretta, MD, 1941–2023.

Published in:: Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1498
Publication type:: Article

Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1450, doi. 10.2967/jnumed.124.267988

By:

Baxi, Siddhartha;
Vohra, Saima;
Hong, Angela;
Mulholland, Nicola;
Heuschkel, Martin;
Dahlhoff, Gerhard;
Cardaci, Giuseppe;
Mirzaei, Siroos;
Sathekge, Mike

Publication type:

Article

The Potential Value of Functional Adrenal Imaging in Primary Aldosterone.

Published in:

2024

By:

Viglianti, Benjamin L.;
Brooks, Allen

Publication type:

Letter

Impact of Posttreatment SPECT/CT on Patient Management During 177Lu-PSMA-617 Radiopharmaceutical Therapy.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1395, doi. 10.2967/jnumed.124.267955

By:

Yadav, Surekha;
Lowery, Blair;
Tuchayi, Abuzar Moradi;
Jiang, Fei;
Saelee, Rachelle;
Aggarwal, Rahul R.;
Juarez, Roxanna;
Flavell, Robert R.;
Hope, Thomas A.

Publication type:

Article

177Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1340, doi. 10.2967/jnumed.124.267951

By:

Poschenrieder, Andreas;
Taleska, Jasminka;
Schaetz, Leonhard

Publication type:

Article

This Month in JNM.

Published in:: Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 8
Publication type:: Article

[68Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1376, doi. 10.2967/jnumed.124.267899

By:

Mainta, Ismini C.;
Neroladaki, Angeliki;
Wolf, Nicola Bianchetto;
Benamran, Daniel;
Boudabbous, Sana;
Zilli, Thomas;
Garibotto, Valentina

Publication type:

Article

Utility of 64Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on 68Ga-PSMA-11 PET/CT.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1371, doi. 10.2967/jnumed.124.267881

By:

Li, Sherrington;
Nguyen, Andrew;
Counter, William;
John, Nikeith C.;
De Leon, Jeremiah;
Hruby, George;
Joshua, Anthony M.;
Stricker, Phillip;
Crumbaker, Megan;
Ayati, Narjess;
Chan, Lyn;
Sabahi, Zahra;
Swiha, Mina;
Kneebone, Andrew;
Wong, Keith;
Liu, Victor;
Sharma, Shikha;
Agrawal, Shikha;
Emmett, Louise M.

Publication type:

Article

StepBrain: A 3-Dimensionally Printed Multicompartmental Anthropomorphic Brain Phantom to Simulate PET Activity Distributions.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1489, doi. 10.2967/jnumed.123.267277

By:

Pirozzi, Maria Agnese;
Gaudieri, Valeria;
Prinster, Anna;
Magliulo, Mario;
Cuocolo, Alberto;
Brunetti, Arturo;
Alfano, Bruno;
Quarantelli, Mario

Publication type:

Article

International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline 18F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1343, doi. 10.2967/jnumed.124.267789

By:

Boellaard, Ronald;
Buvat, Irène;
Nioche, Christophe;
Ceriani, Luca;
Cottereau, Anne-Ségolène;
Guerra, Luca;
Hicks, Rodney J.;
Kanoun, Salim;
Kobe, Carsten;
Loft, Annika;
Schöder, Heiko;
Versari, Annibale;
Voltin, Conrad-Amadeus;
Zwezerijnen, Gerben J.C.;
Zijlstra, Josée M.;
Mikhaeel, N. George;
Gallamini, Andrea;
El-Galaly, Tarec C.;
Hanoun, Christine;
Chauvie, Stephane

Publication type:

Article

Single Chelator–Minibody Theranostic Agents for 89Zr PET Imaging and 177Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1435, doi. 10.2967/jnumed.124.267667

By:

Ho, Khanh-Van;
Tatum, David S.;
Watkinson, Lisa;
Carmack, Terry;
Jia, Fang;
Mascioni, Alessandro;
Maitz, Charles A.;
Magda, Darren;
Anderson, Carolyn J.

Publication type:

Article

18F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1383, doi. 10.2967/jnumed.124.267772

By:

Osman, Medhat M.;
Iravani, Amir;
Mitchell, Catherine;
Hicks, Rodney J.;
Perry, Elisa;
Hofman, Michael S.

Publication type:

Article

Reply: Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions.

Published in:

2024

By:

Duin, Jan J.;
de Barros, Hilda A.;
van Leeuwen, Pim J.;
van der Poel, Henk G.

Publication type:

Letter

Neurologic Symptoms After 177Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1402, doi. 10.2967/jnumed.124.267643

By:

Belge Bilgin, Gokce;
Burkett, Brian J.;
Bilgin, Cem;
Orme, Jacob J.;
Childs, Daniel S.;
Rincon, Miguel Muniz;
Abdelrazek, Ahmad S.;
Johnson, Derek R.;
Johnson, Geoffrey B.;
Kwon, Eugene D.;
Sartor, Oliver;
Kendi, Ayse Tuba

Publication type:

Article

Unrealistic Data Augmentation Improves the Robustness of Deep Learning–Based Classification of Dopamine Transporter SPECT Against Variability Between Sites and Between Cameras.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1463, doi. 10.2967/jnumed.124.267570

By:

Buddenkotte, Thomas;
Buchert, Ralph

Publication type:

Article

Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions.

Published in:

2024

By:

Ah-Thiane, Loic;
Ferrer, Ludovic;
Supiot, Stéphane;
Rousseau, Caroline

Publication type:

Letter

211At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1443, doi. 10.2967/jnumed.124.267540

By:

Frost, Sofia H.L.;
Orozco, Johnnie J.;
Bäck, Tom A.;
Miller, Brian W.;
Santos, Erlinda B.;
Kenoyer, Aimee;
Knoblaugh, Sue E.;
Hamlin, Donald K.;
Wilbur, D. Scott;
Sandmaier, Brenda M.

Publication type:

Article

[177Lu]Lu-Prostate-Specific Membrane Antigen-617 in a Patient with Metastatic Castration-Resistant Prostate Cancer and Status After Bilateral Nephrectomy.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1493, doi. 10.2967/jnumed.124.267533

By:

Huang, Yu-Yi;
Lin, Ting-Chum;
Yang, Shih-Han;
Lai, Lan-Shih;
Hung, Ling-Man;
Li, Ming-Hsin;
Huang, Kuo-Cheng

Publication type:

Article

[177Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1494, doi. 10.2967/jnumed.124.267497

By:

Al-Ibraheem, Akram;
Abdlkadir, Ahmed;
Al-Adhami, Dhuha;
Herrmann, Ken

Publication type:

Article

Development of a 213Bi-Labeled Pyridyl Benzofuran for Targeted α-Therapy of Amyloid-β Aggregates.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1467, doi. 10.2967/jnumed.124.267482

By:

Bender, Aidan A.;
Kirkeby, Emily K.;
Cross, Donna J.;
Minoshima, Satoshi;
Roberts, Andrew G.;
Mastren, Tara E.

Publication type:

Article

Role of 64CuCl2 PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and 18F-FDG PET/CT.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1357, doi. 10.2967/jnumed.124.267474

By:

Piccardo, Arnoldo;
Bottoni, Gianluca;
Puppo, Cristina;
Massollo, Michela;
Ugolini, Martina;
Shoushtari Zadeh Naseri, Mehrdad;
Melani, Enrico;
Tomasello, Laura;
Boitano, Monica;
DeCensi, Andrea;
Sambucco, Beatrice;
Campodonico, Fabio;
Altrinetti, Vania;
Ennas, Marco;
Urru, Alessia;
Negro, Carlo Luigi Augusto;
Timossi, Luca;
Treglia, Giorgio;
Introini, Carlo;
Fiz, Francesco

Publication type:

Article

Elevated Baseline Mean Corpuscular Volume Predicts the Development of Severe Hematologic Toxicity After 177Lu-DOTATATE Therapy.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1423, doi. 10.2967/jnumed.124.267462

By:

Voter, Andrew F.;
Gafita, Andrei;
Werner, Rudolf A.;
De Jesus-Acosta, Ana;
Rowe, Steven P.;
Solnes, Lilja B.

Publication type:

Article

Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1416, doi. 10.2967/jnumed.123.267363

By:

Fosse, Aurelien;
Hadoux, Julien;
Girot, Paul;
Beron, Amandine;
Afchain, Pauline;
Cottereau, Anne-Segolene;
Baudin, Eric;
Dierickx, Lawrence O.;
Lecomte, Thierry;
Perrier, Marine;
Lepage, Come;
Bouhier-Leporrier, Karine;
Goichot, Bernard;
Lachachi, Boumediene;
Walter, Thomas;
Durand, Alice

Publication type:

Article

Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1473, doi. 10.2967/jnumed.123.267273

By:

Gebre, Robel K.;
Rial, Alexis Moscoso;
Raghavan, Sheelakumari;
Wiste, Heather J.;
Heeman, Fiona;
Costoya-Sánchez, Alejandro;
Schwarz, Christopher G.;
Spychalla, Anthony J.;
Lowe, Val J.;
Graff-Radford, Jonathan;
Knopman, David S.;
Petersen, Ronald C.;
Schöll, Michael;
Murray, Melissa E.;
Jack Jr., Clifford R.;
Vemuri, Prashanthi

Publication type:

Article

61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1427, doi. 10.2967/jnumed.123.267126

By:

Basaco Bernabeu, Tais;
Mansi, Rosalba;
Del Pozzo, Luigi;
Zanger, Sandra;
Gaonkar, Raghuvir H.;
McDougall, Lisa;
De Rose, Francesco;
Jaafar-Thiel, Leila;
Herz, Michael;
Eiber, Matthias;
Ulaner, Gary A.;
Weber, Wolfgang A.;
Fani, Melpomeni

Publication type:

Article

Total-Body Dynamic Imaging and Kinetic Modeling of [18F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1481, doi. 10.2967/jnumed.123.267003

By:

Omidvari, Negar;
Levi, Jelena;
Abdelhafez, Yasser G.;
Wang, Yiran;
Nardo, Lorenzo;
Daly, Megan E.;
Wang, Guobao;
Cherry, Simon R.

Publication type:

Article

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1409, doi. 10.2967/jnumed.123.266956

By:

Severi, Stefano;
Grassi, Ilaria;
Bongiovanni, Alberto;
Nicolini, Silvia;
Marini, Irene;
Arpa, Donatella;
Ranallo, Nicoletta;
Azzali, Irene;
Di Iorio, Valentina;
Sarnelli, Anna;
Manuela, Monti;
Amadori, Elena;
Fabbri, Lucia;
Bartolini, Daniela;
Tosatto, Luigino;
Di Meco, Francesco;
Gurrieri, Lorena;
Riva, Nada;
Calabro, Luana;
Matteucci, Federica

Publication type:

Article

Paraplegic Patient with Metastatic Papillary Thyroid Cancer: A Multidisciplinary Approach to Radioactive Iodine Therapy Safety and Efficacy Strategy.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1336, doi. 10.2967/jnumed.123.266955

By:

Al-Naqeeb, Ghadah;
Munger, Eric;
Ramanathan, Amrita L.;
Makarewicz, Andrew;
Behairy, Noha;
Veraraghavan, Padmasree;
Cochran, Craig;
Bernaldez, Philip;
Clinton, Iman;
Devaraj, Newbegin;
Lee, Korressa;
Fisher, Teresa;
Owoade, Olumide;
Maass-Moreno, Roberto;
Saboury, Babak;
Gubbi, Sriram;
Klubo-Gwiezdzinska, Joanna

Publication type:

Article

Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1349, doi. 10.2967/jnumed.123.266469

By:

Ince, Semra;
Laforest, Richard;
Itani, Malak;
Prasad, Vikas;
Derenoncourt, Paul-Robert;
Crandall, John P.;
Ashrafinia, Saeed;
Smith, Anne M.;
Wahl, Richard L.;
Fraum, Tyler J.

Publication type:

Article

Theranostic Intratumoral Convection-Enhanced Delivery of 124I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.

Published in:

Journal of Nuclear Medicine, 2024, v. 65, n. 9, p. 1364, doi. 10.2967/jnumed.123.266365

By:

Pandit-Taskar, Neeta;
Zanzonico, Pat B.;
Grkovski, Milan;
Donzelli, Maria;
Vietri, Scott M.;
Horan, Christopher;
Serencsits, Brian;
Prasad, Kavya;
Lyashchenko, Serge;
Kramer, Kim;
Dunkel, Ira J.;
Souweidane, Mark M.

Publication type:

Article

Works matching IS 01615505 AND DT 2024 AND VI 65 AND IP 9

Prostate-Specific Membrane Antigen PET/CT–Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate Cancer.

Radiolabeling and Preclinical Evaluation of Therapeutic Efficacy of <sup>225</sup>Ac-ch806 in Glioblastoma and Colorectal Cancer Xenograft Models.

FINDing the Future of Radiopharma.

Reply: The Potential Value of Functional Adrenal Imaging in Primary Aldosterone.

Robert Carretta, MD, 1941–2023.

Effectiveness and Patient Experiences of Rhenium Skin Cancer Therapy for Nonmelanoma Skin Cancer: Interim Results from the EPIC-Skin Study.

The Potential Value of Functional Adrenal Imaging in Primary Aldosterone.

Impact of Posttreatment SPECT/CT on Patient Management During <sup>177</sup>Lu-PSMA-617 Radiopharmaceutical Therapy.

<sup>177</sup>Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?

This Month in JNM.

[<sup>68</sup>Ga]Ga-PSMA-11 PET and Prostate Cancer Bone Metastases: Diagnostic Performance of Available Standardized Criteria.

Utility of <sup>64</sup>Cu-Sarcophagine-Bombesin PET/CT in Men with Biochemically Recurrent Prostate Cancer and Negative or Equivocal Findings on <sup>68</sup>Ga-PSMA-11 PET/CT.

StepBrain: A 3-Dimensionally Printed Multicompartmental Anthropomorphic Brain Phantom to Simulate PET Activity Distributions.

International Benchmark for Total Metabolic Tumor Volume Measurement in Baseline <sup>18</sup>F-FDG PET/CT of Lymphoma Patients: A Milestone Toward Clinical Implementation.

Single Chelator–Minibody Theranostic Agents for <sup>89</sup>Zr PET Imaging and <sup>177</sup>Lu Radiopharmaceutical Therapy of PSMA-Expressing Prostate Cancer.

<sup>18</sup>F-DCFPyL PSMA PET/CT Tracheobronchial Uptake in Patients with Prostate Cancer: Incidence and Etiology.

Reply: Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions.

Neurologic Symptoms After <sup>177</sup>Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience.

Unrealistic Data Augmentation Improves the Robustness of Deep Learning–Based Classification of Dopamine Transporter SPECT Against Variability Between Sites and Between Cameras.

Considerations Surrounding the Sentinel Lymph Node in Prostate Cancer and Unanswered Questions.

<sup>211</sup>At-Labeled Anti-CD45 Antibody as a Nonmyeloablative Conditioning for Canine DLA-Haploidentical Stem Cell Transplantation.

[<sup>177</sup>Lu]Lu-Prostate-Specific Membrane Antigen-617 in a Patient with Metastatic Castration-Resistant Prostate Cancer and Status After Bilateral Nephrectomy.

[<sup>177</sup>Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid.

Development of a <sup>213</sup>Bi-Labeled Pyridyl Benzofuran for Targeted α-Therapy of Amyloid-β Aggregates.

Role of <sup>64</sup>CuCl<sub>2</sub> PET/CT in Detecting and Staging Muscle-Invasive Bladder Cancer: Comparison with Contrast-Enhanced CT and <sup>18</sup>F-FDG PET/CT.

Elevated Baseline Mean Corpuscular Volume Predicts the Development of Severe Hematologic Toxicity After <sup>177</sup>Lu-DOTATATE Therapy.

Peptide Receptor Radionuclide Therapy or Everolimus in Metastatic Neuroendocrine Tumors: The SeqEveRIV Study, a National Study from the French Group of Endocrine Tumors and Endocan–RENATEN Network.

Advancing Tau PET Quantification in Alzheimer Disease with Machine Learning: Introducing THETA, a Novel Tau Summary Measure.

<sup>61</sup>Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging.

Total-Body Dynamic Imaging and Kinetic Modeling of [<sup>18</sup>F]F-AraG in Healthy Individuals and a Non–Small Cell Lung Cancer Patient Undergoing Anti–PD-1 Immunotherapy.

Peptide Receptor Radionuclide Therapy in Advanced Refractory Meningiomas: Efficacy and Toxicity in a Long Follow-up.

Paraplegic Patient with Metastatic Papillary Thyroid Cancer: A Multidisciplinary Approach to Radioactive Iodine Therapy Safety and Efficacy Strategy.

Quantitative Assessments of Tumor Activity in a General Oncologic PET/CT Population: Which Metric Minimizes Tracer Uptake Time Dependence?

Theranostic Intratumoral Convection-Enhanced Delivery of <sup>124</sup>I-Omburtamab in Patients with Diffuse Intrinsic Pontine Glioma: Pharmacokinetics and Lesion Dosimetry.